On 19 July 2024, the China Securities Regulatory Commission announced that Xunfei Healthcare (讯飞医疗科技, also known as iFlyHealth), a medical artificial intelligence startup, has “filed” (备案) for listing in Hong Kong.

Earlier in January 2024, iFlyHealth filed a draft prospectus on the Hong Kong stock exchange website.

China Merchants China Direct Investments (CMCDI 133 HK) owns 3.4% stake in non-listed iFlyHealth, which acounts for 5.3% of CMCDI’s total assets.

iFlyHealth is a spin-off of iFlytek, the developer of a top-notch Chinese large language model. CMCDI also owns 0.3% shares in iFlytek, which is already listed and accounts for 5.3% of CMCDI’s total assets.

You can chat with iFlyheath’s chatbot to get medical advice:

We, Argyle Street Management, hope that the IPO will really fly.

Chat with us on WeChat or Whatsapp:

💬 WeChat ID: ASM_Argyle

💬 WhatsApp ID: +852 6317 6371

🖥️ UnlockValueChinaMerchants.com

📧 ChinaMerchants@asmhk.com


2024年7月19日,中国证券会公布,医疗人工智能公司讯飞医疗(也被称为iFlyHealth)就在香港发行上市及境内未上市股份“全流通”通过备案,获取备案通知书。

早在2024年1月,讯飞医疗已经向香港交易所提交了招股说明书草案

招商局中国基金(中国基金,133 HK)持有未上市的讯飞医疗 3.4%的股份,占其总资产的5.3%

讯飞医疗是讯飞科技分拆而来的公司,讯飞科技是中国顶尖的大语言模型开发公司。中国基金持有讯飞科技0.3%的股份,讯飞科技已经上市,占中国基金总资产的5.3%

您可以与讯飞医疗的聊天机器人交流以获取医疗建议:

我们Argyle Street Management希望其IPO一切顺利。

欢迎与我们联系:

💬 微信: ASM_Argyle

💬 WhatsApp ID: +852 6317 6371

🖥️ UnlockValueChinaMerchants.com

📧 ChinaMerchants@asmhk.com

Leave a comment